High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial.

Saved in:
Bibliographic Details
Title: High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial.
Transliterated Title: Altas dosis de quimioterapia DICEP frente a observación en pacientes con cáncer de mama metastásico con enfermedad monotópica que responden a quimioterapia inducida con paclitaxel más epirubicina. Resultados finales del ensayo GEICAM en fase III
Authors: Martín, Miguel, García-Puche, José, Casado, Antonio, Talavera, María, Menéndez, María, Alba, Emilio, Pelegrí, Amadeu, Balil, Ana, Rodríguez-Lescure, Álvaro, Casinello, Javier, Lozano, Ana, Pérez-Carrión, Ramón, Virizuela, José, Aranda, Enrique, Oltra, Amparo, Díaz-Rubio, Eduardo
Source: Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Apr2003; Vol. 5 (3).
Journal Info: Publisher: Springer Nature ISSN: 1699-048X
Database: MEDLINE Ultimate
Description
ISSN:1699-3055
DOI:10.1007/BF02712849